These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8653714

  • 1. Epidermal growth factor-responsive and -refractory carcinomas initiated with N-methyl-N-nitrosourea in rat urinary bladder.
    Fujimoto K, Tanaka Y, Rademaker A, Oyasu R.
    Cancer Res; 1996 Jun 01; 56(11):2666-70. PubMed ID: 8653714
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM.
    Cancer Res; 1990 Apr 15; 50(8):2530-7. PubMed ID: 1690599
    [Abstract] [Full Text] [Related]

  • 3. Persistence of carcinogen-altered cell population in rat urothelium which can be promoted to tumors by chronic inflammatory stimulus.
    Kawai K, Kawamata H, Kemeyama S, Rademaker A, Oyasu R.
    Cancer Res; 1994 May 15; 54(10):2630-2. PubMed ID: 8168089
    [Abstract] [Full Text] [Related]

  • 4. Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis.
    Momose H, Kakinuma H, Shariff SY, Mitchell GB, Rademaker A, Oyasu R.
    Cancer Res; 1991 Oct 15; 51(20):5487-90. PubMed ID: 1913668
    [Abstract] [Full Text] [Related]

  • 5. Conversion from low grade to high grade of rat urinary bladder carcinomas.
    Samma S, Oyasu R.
    Cancer Res; 1988 Mar 01; 48(5):1265-9. PubMed ID: 3342406
    [Abstract] [Full Text] [Related]

  • 6. A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.
    Thøgersen VB, Sørensen BS, Poulsen SS, Orntoft TF, Wolf H, Nexo E.
    Cancer Res; 2001 Aug 15; 61(16):6227-33. PubMed ID: 11507076
    [Abstract] [Full Text] [Related]

  • 7. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
    Lee CC, Yamamoto S, Wanibuchi H, Wada S, Sugimura K, Kishimoto T, Fukushima S.
    Cancer Res; 1997 Nov 01; 57(21):4765-76. PubMed ID: 9354438
    [Abstract] [Full Text] [Related]

  • 8. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T, Schlott T, Korabiowska M, Käthei N, Zöller G, Glaser F, Kunze E.
    Anticancer Res; 2004 Nov 01; 24(5A):2745-56. PubMed ID: 15517881
    [Abstract] [Full Text] [Related]

  • 9. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C, Klasmeyer K, Bojar H, Schulz WA, Ackermann R, Grimm MO.
    Cancer; 2007 May 15; 109(10):2016-24. PubMed ID: 17394193
    [Abstract] [Full Text] [Related]

  • 10. Intraluminal epidermal growth factor affects growth of N-methyl-N-nitrosourea-initiated rat bladder carcinoma.
    Kawai K, Kawamata H, Kameyama S, Rademaker A, Oyasu R.
    Jpn J Cancer Res; 1995 May 15; 86(5):429-34. PubMed ID: 7790316
    [Abstract] [Full Text] [Related]

  • 11. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.
    Yura Y, Hayashi O, Kelly M, Oyasu R.
    Cancer Res; 1989 Mar 15; 49(6):1548-53. PubMed ID: 2784351
    [Abstract] [Full Text] [Related]

  • 12. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
    Hudgins WR, Orth DN, Stromberg K.
    Cancer Res; 1988 Mar 15; 48(6):1428-34. PubMed ID: 3257897
    [Abstract] [Full Text] [Related]

  • 13. Exogenous epidermal growth factor exerts promoting action during the early phase of rat urinary bladder carcinogenesis.
    Hattori K, Fujimoto K, Tamatani T, Rademaker A, Oyasu R.
    Jpn J Cancer Res; 1998 Oct 15; 89(10):991-4. PubMed ID: 9849575
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK.
    Urol Oncol; 2004 Oct 15; 22(2):93-101. PubMed ID: 15082004
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhancement of rat urinary bladder tumorigenesis by lipopolysaccharide-induced inflammation.
    Kawai K, Yamamoto M, Kameyama S, Kawamata H, Rademaker A, Oyasu R.
    Cancer Res; 1993 Nov 01; 53(21):5172-5. PubMed ID: 8221653
    [Abstract] [Full Text] [Related]

  • 17. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli.
    Yamamoto M, Wu HH, Momose H, Rademaker A, Oyasu R.
    Cancer Res; 1992 Oct 01; 52(19):5329-33. PubMed ID: 1394138
    [Abstract] [Full Text] [Related]

  • 18. Irreversibility of low-grade superficial rat bladder carcinomas.
    Ozono S, Numata I, Oyasu R.
    Cancer Res; 1984 Oct 01; 44(10):4260-2. PubMed ID: 6467186
    [Abstract] [Full Text] [Related]

  • 19. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 May 01; 416():1-482. PubMed ID: 12616295
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of transforming growth factor-alpha and epidermal growth factor receptors in rat chronic reflux esophagitis.
    Fujiwara Y, Higuchi K, Hamaguchi M, Takashima T, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Arakawa T.
    J Gastroenterol Hepatol; 2004 May 01; 19(5):521-7. PubMed ID: 15086595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.